Is a complete ACRV research report available?

No complete published report is available for Acrivon Therapeutics, Inc. (ACRV) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Acrivon Therapeutics, Inc. (ACRV)

NASDAQ: ACRV · USD

$1.52

+0.09 (+6.3%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ACRV analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	65.1M
Net income (ttm)	-77.3M
EPS (ttm)	-$2.00
Shares out	42.8M
Volume	384,323
Beta	1.83
Price target	$11.5	+656.6%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -77.3M
EPS (ttm): -$2.00
Market cap: 65.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All ACRV indicators

Market & fundamental data

Available fields

185

Groups with data

Currency

USD

Showing 185 of 185 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001781174
Company name	Acrivon Therapeutics, Inc.
Country	United States
Country code	US
Cusip	004890109
Employees	76
Employees Change	-2%
Employees Change Percent	-2.56
Enterprise value	$-32.8M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2022-11-15
Isin	US0048901096
Last refreshed	2026-07-31
Market cap	$65.1M
Market cap category	Micro-Cap
Price	$1.52
Price currency	USD
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	2834
Symbol	ACRV
Website	https://acrivon.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-123.65%
FCF yield	-106.08%
P/B ratio	0.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-77.3M
Net Income Growth Quarters	3%
Net Income Growth Years	1%
Profit Per Employee	$-1M
ROA	-36.22
Roa5y	-24.91
ROCE	-85.1
ROE	-60.39
Roe5y	-40.98
ROIC	-39.32

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	14.3%
Cagr3y	-50.44%
EPS Growth Quarters	3
EPS Growth Years	4
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$107.8M
Cash	$97.7M
Current Assets	$99.2M
Current Liabilities	$11.1M
Debt	$2.4M
Debt Equity	$0.03
Equity	$95.5M
Liabilities	$12.3M
Long Term Assets	$8.6M
Long Term Liabilities	$1.3M
Net Cash	$95.3M
Net Cash By Market Cap	$153
Net Cash Growth	-34.77%
Net Debt Equity	$-1
Tangible Book Value	$95.5M
Tangible Book Value Per Share	$2.47
WACC	13.8

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.98
Net Working Capital	$-8.4M
Quick ratio	8.84
Working Capital	$88.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.31%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	14.29%
200-day SMA	1.87
3Y total return	-87.83%
50-day SMA	1.66
50-day SMA vs 200-day SMA	50under200
All Time High	25.47
All Time High Change	-94.03%
All Time High Date	2023-02-06
All Time Low	1.05
All Time Low Change	44.76%
All Time Low Date	2025-05-30
ATR	0.12
Beta	1.83
Beta1y	1.86
Beta2y	1.87
Ch YTD	-36.93
High	1.54
High52	3.56
High52 Date	2026-01-07
High52ch	-57.3%
Low	1.41
Low52	1.2
Low52 Date	2025-08-11
Low52ch	26.67%
Ma50ch	-8.54%
Premarket Change Percent	0.7
Premarket Price	$1.44
Price vs 200-day SMA	-18.5%
RSI	39.64
RSI Monthly	37.82
RSI Weekly	44.2
Sharpe ratio	0.56x
Sortino ratio	0.95
Total Return	-2.31%
Tr YTD	-36.93
Tr1m	-14.61%
Tr1w	-8.98%
Tr3m	-16.02%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	8
Analyst Count Top	2
Analyst Price Target Top	$8
Analyst Ratings	Strong Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.5
Earnings Revenue Estimate	464,000x
Operating Income	$-82.4M
Price target	$11.5
Price Target Change	$657
Price Target Change Top	$426

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	27,929,981%
Float Percent	65.25%
Shares Insiders	6.17%
Shares Institutions	27.54%
Shares Out	42,801,729
Shares Qo Q	0.17%
Shares Yo Y	2.31%
Short Float	5.33%
Short Ratio	2.95
Short Shares	3.48

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-79.4M
Adjusted OCF	-77,778,000
Average Volume	469,977.65x
Bv Per Share	2.47
CAPEX	$-1.6M
Ch1m	-14.61
Ch1w	-8.98
Ch1y	14.29
Ch3m	-16.02
Ch3y	-87.83
Ch6m	-19.15
Change	6.29%
Change From Open	6.29
Close	1.43
Days Gap	0
Depreciation Amortization	1,428,000
Dollar Volume	584,171
Earnings Date	2026-08-11
Earnings Time	amc
EBIT	$-82.4M
EBITDA	$-80.9M
EPS	$-2
F Score	1
FCF	$-66.3M
FCF EV Yield	201.92x
FCF Per Share	$-1.55
Financing CF	-439,000
Fiscal Year End	December
Founded	2,018
Investing CF	60,013,000
Ipr	-88.32
Iprfo	-89.06
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-13
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-19
Ma150	1.76
Ma150ch	-13.39%
Ma20	1.77
Ma20ch	-14.22%
Net CF	-5,094,000
Next Earnings Date	2026-08-12
Open	1.43
Optionable	No
Position In Range	84.62
Post Close	1.52
Postmarket Change Percent	1.97
Postmarket Price	$1.55
Ppne	6,908,000
Pre Close	1.43
Price Date	2026-07-30
Ptbv Ratio	0.65
Relative Volume	0.82x
Share Based Comp	13,110,000
Tr6m	-19.15%
Us State	Massachusetts
Volume	384,323

Acrivon Therapeutics, Inc. (ACRV)

Coverage state: Market snapshot only — no published research

Generate the first ACRV analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · ACRV

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ACRV indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ACRV

Frequently asked questions